Autoantibody profile in systemic sclerosis as a marker for esophageal and other organ involvement in Turkish populations

Digestive Diseases and Sciences

Volumn 52, Issue 11, 2007, Pages 3081-3086

  Savas, Nurten ^a   Dagli, Ulku ^b   Ertugrul, Esin ^c   Kuran, Sedef ^b   Sahin, Burhan ^b  

^a BASKENT UNIVERSITY   (Turkey)

^b TURKIYE YUKSEK IHTISAS HOSPITAL   (Turkey)

^c ANKARA UNIVERSITY   (Turkey)

Author keywords

Autoantibodies; Esophageal involvement; Heart involvement; Pulmonary involvement; Systemic sclerosis

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; CENTROMERE ANTIBODY; SCL 70 ANTIBODY;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ESOPHAGUS FUNCTION; FEMALE; GROUPS BY AGE; HUMAN; MALE; MANOMETRY; PRIORITY JOURNAL; SKIN BIOPSY; STATISTICAL ANALYSIS; SYSTEMIC SCLEROSIS; TURKEY (REPUBLIC);

ADULT; ANTIBODIES, ANTINUCLEAR; AUTOANTIBODIES; BIOLOGICAL MARKERS; CENTROMERE; DNA TOPOISOMERASES, TYPE I; ECHOCARDIOGRAPHY, DOPPLER; ELECTROCARDIOGRAPHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESOPHAGEAL DISEASES; ESOPHAGUS; FEMALE; FOLLOW-UP STUDIES; HEART DISEASES; HUMANS; INCIDENCE; LUNG DISEASES; MALE; MANOMETRY; MIDDLE AGED; NUCLEAR PROTEINS; PRESSURE; RESPIRATORY FUNCTION TESTS; RNA; SCLERODERMA, SYSTEMIC; TURKEY;

EID: 34848850139     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-007-9809-1     Document Type: Article

References (27)

1. Steen VD, Medsger TA Jr (2000) Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum 43(11):2437-2444
2. Sallam H, Mcnearney TA, Chen JDZ (2006) Systematic review:pathophysiology and management of gastrointestinal dysmotility in systemic sclerosis. Aliment Pharmacol Ther 23:691-712
3. Ehrmann S (1903) Ueber die Bieziehung der Sklerodermie Zu den Autotoxichen erythemen. Ubien Med Wschr 53:1097-1159
4. Ebert EC (2006) Esophageal disease in scleroderma. J Clin Gastroenterol 40:769-775
5. Poirier TJ, Rankin GB (1972) Gastrointestinal manifestations of progressive systemic scleroderma based on a review of 364 cases. Am J Gastroenterol 58:30-44
6. Rose S, Young MA, Reynolds JC (1998) Gastrointestinal manifestations of scleroderma. Gastroenterol Clin North Am 27(3):563-594
7. Cohen S (1979) Motor disorders of the esophagus. N Engl J Med 301(4):184-192
8. Lock G, Pfeifer M, Straub RH, Zeuner M, Lang B, Schölmerich J, Holstege A (1998) Association of esophageal dysfunction and pulmonary function impairment in systemic sclerosis. Am J Gastroenterol 93:341-345
9. Ferri C, Giuggioli D, Sebastiani M, Colaci M, Emdin M (2005) Heart involvement and systemic sclerosis. Lupus 14:702-707
10. Gonzalez R, Storr M, Bloching H, Seige M, Ott R, Allescher HD (2001) Autoantibody profile in progressive systemic sclerosis as markers for esophageal involvement. J Clin Gastroenterol 32(2):123-127
11. Preliminary criteria for the classification of systemic sclerosis. Subcommittee for scleroderma criteria of the American Rheumatism Association. Arthritis Rheum 23:581-590
12. Richter JE, Wu WC, Johns DN, Blackwell JN, Nelson JL 3rd, Castell JA, Castell DO (1987) Esohageal manometry in 95 healthy adult volunteers Variability of pressures with age and frequency ob 'abnormal' contractions. Dig Dis Sci 32:583-592
13. Paolo A, Casa DD, Danieli E, Missale G, Cattaneo R, Cestari R (2005) Oesophageal manometry in early and definite systemic sclerosis. Clin Rheumatol 24:370-376
14. Murata I, Takenaka K, Yoshinoya S, Kikuchi K, Kiuchi T, Tanigawa T, Ito K (1997) Clinical evaluation of pulmonary hypertension in systemic sclerosis and related disorders. Chest 111:36-43
15. Ferri C, Valentini G, Cozzi F, et al. (2002) Systemic sclerosis: demographic, clinical, and serologic features and survival in 1012 Italian patients. Medicine 81:139-153
16. Catoggio LJ, Bernstein RM, Black CM, Hughes GRV, Maddison PJ (1983) Serological markers in progressive systemic sclerosis:clinical correlations. Ann-Rheum Dis 42(1):23-27
17. Mayes MD, Lacey JV, Beebe-Dimmer J, Gillespie W, Cooper B, Laing TJ, Schottenfeld D (2003) Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arth Rheum 48(8):2246-2255
18. Furst DE, Clements PJ, Wong WK, Mayes MD, Wigley F, White B, Weisman M, Barr W, Moreland L, Martin R, Medsger TA, Steen V, Collier D, Weinstein A, Lally E, Varga J, Weiner SR, Andrews B, Abeles M, Peter JB, Seibold JR (2001) Effects of American college of rheumatology systemic sclerosis trial guidelines on the nature of systemic sclerosis patients entering a clinical trial. Rheumatology 40(6):615-622
19. Marie I, Dominique S, Levesque H, Ducrotte P, DenIs P, Hellot MF, Courtois H (2001) Esophageal involvement and pulmonary manifestations in systemic sclerosis. Arth Rheum 45:346-354
20. Ioannidis JPA, Vlachoyiannopoulos PG, Haidich AB, Medsger TA, Lucas M, Michet CJ, Kuwana M, Yasuaka H, Hoogen F, Boome L, Laar JM, Verbeet NL, Matucci-Cerinic M, Georgountzos A, Moutsopoulos HM. Mortality in systemic sclerosis:an international meta-analysis of individual patient data. Am J Med 118:2-10
21. Bryan C, Knight C, Black CM, Silman AJ (1999) Prediction of five-year survival following presentation with scleroderma:development of a simple model using using three disease factors at first visit. Arth Rheum 42:2660-2665
22. Miller MH, Littlejohn GO, Davidson A, Jones B, Topliss DJ (1987) The clinical significance of the anticentromere antibody. Br J Rheumatol 26:17-21
23. Yarze JC, Varga J, Stampfl D, Castell DO, Jimenez SA (1993) Esophageal function in systemic sclerosis:A prospective evaluation of motility and acid reflux in 36 patients. Am J Gastroenterol 88(6):870-876
24. Steen VD, Ziegler GL, Rodnan GP, Medsger TA (1984) Clinical and laboratory associations of anticentromere antibody in patients with progressive systemic sclerosis. Arth Rheum 27(2):125-131
25. Kallenberg CG, Pastoor GW, Wouda AA, The TH (1982) Antinuclear antibodies in patients with Raynoud's phenomenon:clinical significance of anticentromer antibodies. Ann Rheum Dis 41:382-387
26. Fritzler MJ, Kinsella TD (1980) The CREST syndrome a distinct serologic entitity with anticentromere antibodies. Am J Med 69:520-526
27. McCarty GA, Rice JR, Bembe ML, Barada FA Jr (1983) Anticentromere antibody. Clinical correlations and association with favorable prognosis in patients with scleroderma variants. Arth Rheum 26:1-7